Back to User profile » Dr Shan Lin
Papers published by Dr Shan Lin:
Overexpression of HOXB4 Promotes Protection of Bone Marrow Mesenchymal Stem Cells Against Lipopolysaccharide-Induced Acute Lung Injury Partially Through the Activation of Wnt/β-Catenin Signaling [Corrigendum]
Lin S, Chen Q, Zhang L, Ge S, Luo Y, He W, Xu C, Zeng M
Journal of Inflammation Research 2021, 14:4229-4231
Published Date: 30 August 2021
Overexpression of HOXB4 Promotes Protection of Bone Marrow Mesenchymal Stem Cells Against Lipopolysaccharide-Induced Acute Lung Injury Partially Through the Activation of Wnt/β-Catenin Signaling
Lin S, Chen Q, Zhang L, Ge S, Luo Y, He W, Xu C, Zeng M
Journal of Inflammation Research 2021, 14:3637-3649
Published Date: 27 July 2021
Sex Differences in Short- and Long-Term Survival Among Critically Ill Patients with Sepsis
Lin S, He W, Hu Z, Bai L, Zeng M
International Journal of General Medicine 2021, 14:613-622
Published Date: 25 February 2021
Association of Diabetes and Admission Blood Glucose Levels with Short-Term Outcomes in Patients with Critical Illnesses
Lin S, He W, Zeng M
Journal of Inflammation Research 2020, 13:1151-1166
Published Date: 22 December 2020
The Association of Red Blood Cell Distribution Width to Platelet Count Ratio and 28-Day Mortality of Patients with Sepsis: A Retrospective Cohort Study
Ge S, Lin S, Zhang L, Zeng M
Therapeutics and Clinical Risk Management 2020, 16:999-1006
Published Date: 19 October 2020
Diagnostic Accuracy of Interleukin-27 in Bronchoalveolar Lavage Fluids for Pulmonary Tuberculosis
Lin S, Wang Y, Li Y, Xiao D, Guo J, Ma W, An W, Liu H, Shi Y, Zhang L, Cui J, Guan W
Infection and Drug Resistance 2019, 12:3755-3763
Published Date: 2 December 2019
Dabigatran must be used carefully: literature review and recommendations for management of adverse events
Lin S, Wang Y, Zhang L, Guan W
Drug Design, Development and Therapy 2019, 13:1527-1533
Published Date: 6 May 2019